Revenue YoY
+3.48%
Operating Income YoY
+38.37%
Net Income YoY
+54.50%
Net Margin Δ
+1024 bps
Net income bridge for Gilead Sciences (GILD) — TTM through Q1 2026 vs TTM through Q1 2025
Δ Net income: $3.25B+54.50%
Profit bridge breakdown for Gilead Sciences (GILD) — TTM through Q1 2026 vs TTM through Q1 2025
| Driver | Contribution | % of Δ |
|---|---|---|
| Prior Net Income | $5.96B | — |
| Revenue | $1.00B | +30.8% |
| Cost of Revenue | $100.00M | +3.1% |
| Operating Expenses | $2.05B | +63.2% |
| Other Income / Expense | $749.00M | +23.0% |
| Income Tax | −$651.00M | -20.0% |
| Net Income | $9.22B | — |
- Prior Net Income$5.96B
- Revenue$1.00B
- Cost of Revenue$100.00M
- Operating Expenses$2.05B
- Other Income / Expense$749.00M
- Income Tax−$651.00M
- Net Income$9.22B
Identity check: drivers reconcile to ΔNI within $1.00M ✓
Want the full P&L structure?Income Statement Waterfall
Frequently asked questions
Data & methodology
Gilead Sciences (GILD) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Cash Flow
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement